Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
|
|
Celator Pharmaceuticals Inc (CPXX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/13/2016 |
4
| Kollender Richard S (Director) has filed a Form 4 on Celator Pharmaceuticals Inc|
Txns:
| Exercised (in-or-at-the-money) 40,614 shares
@ $0
Exercised (in-or-at-the-money) 47,265 shares
@ $0
Unknown transaction of 1,327,888 shares
@ $30.25, valued at
$40.2M
Unknown transaction of 637,962 shares
@ $30.25, valued at
$19.3M
Exercised (in-or-at-the-money) 16,391 warrants
@ $5.2123, valued at
$85.4k
Exercised (in-or-at-the-money) 19,076 warrants
@ $5.2123, valued at
$99.4k
Exercised (in-or-at-the-money) 30,708 warrants
@ $3.58, valued at
$109.9k
Exercised (in-or-at-the-money) 35,737 warrants
@ $3.58, valued at
$127.9k
Disposed/sold 28,000 options to buy
@ $3.116, valued at
$87.2k
Disposed/sold 14,000 options to buy
@ $2.8, valued at
$39.2k
Disposed/sold 14,000 options to buy
@ $2.6, valued at
$36.4k
|
|
| 07/12/2016 |
4
| Kovner Bruce (See Remarks Section) has filed a Form 4 on Celator Pharmaceuticals Inc|
Txns:
| Unknown transaction of 1,591,750 shares
@ $30.25, valued at
$48.2M
Unknown transaction of 564,222 shares
@ $30.25, valued at
$17.1M
Disposed of 34,647 warrants
@ $5.2123, valued at
$180.6k
Disposed of 889,403 warrants
@ $3.58, valued at
$3.2M
|
|
| 07/12/2016 |
4
| Morenstein Scott D (Director) has filed a Form 4 on Celator Pharmaceuticals Inc|
Txns:
| Disposed/sold 6,277 shares
@ $30.25, valued at
$189.9k
Unknown transaction of 1,039,109 shares
@ $30.25, valued at
$31.4M
Disposed/sold 14,000 options to buy
@ $2.6, valued at
$36.4k
Disposed/sold 14,000 options to buy
@ $2.8, valued at
$39.2k
Disposed/sold 28,000 options to buy
@ $3.116, valued at
$87.2k
Disposed/sold 358 warrants
@ $3.58, valued at
$1.3k
Unknown transaction of 314,611 warrants
@ $3.58, valued at
$1.1M
|
|
| 07/12/2016 |
4
| Valence Life Sciences GP II LLC (Member of a 10% Group) has filed a Form 4 on Celator Pharmaceuticals Inc|
Txns:
| Disposed of 44,740 warrants
@ $3.58, valued at
$160.2k
Unknown transaction of 1,039,109 shares
@ $30.25, valued at
$31.4M
Unknown transaction of 143,986 shares
@ $30.25, valued at
$4.4M
Disposed of 314,611 warrants
@ $3.58, valued at
$1.1M
|
|
| 07/12/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/12/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/12/2016 |
4
| BIZZARI JEAN-PIERRE (Director) has filed a Form 4 on Celator Pharmaceuticals Inc |
| 07/12/2016 |
4
| Lobacki Joseph M (Director) has filed a Form 4 on Celator Pharmaceuticals Inc |
| 07/12/2016 |
4
| Jackson Scott Thomas (CEO) has filed a Form 4 on Celator Pharmaceuticals Inc |
| 07/12/2016 |
4
| MOLLICA JOSEPH A (Director) has filed a Form 4 on Celator Pharmaceuticals Inc|
Txns:
| Disposed/sold 26,668 options to buy
@ $3.37, valued at
$89.9k
Disposed/sold 28,000 options to buy
@ $3.116, valued at
$87.2k
Disposed/sold 14,000 options to buy
@ $2.8, valued at
$39.2k
Disposed/sold 14,000 options to buy
@ $2.6, valued at
$36.4k
|
|
| 07/12/2016 |
4
| DOUGHERTY MICHAEL R (Executive Chairman) has filed a Form 4 on Celator Pharmaceuticals Inc|
Txns:
| Disposed/sold 20,000 shares
@ $30.25, valued at
$605k
Disposed/sold 28,000 options to buy
@ $3.116, valued at
$87.2k
Disposed/sold 14,000 options to buy
@ $2.8, valued at
$39.2k
Disposed/sold 20,600 options to buy
@ $2.65, valued at
$54.6k
Disposed/sold 22,000 options to buy
@ $2.6, valued at
$57.2k
Disposed/sold 500,000 options to buy
@ $2.18, valued at
$1.1M
Disposed/sold 75,000 options to buy
@ $1.32, valued at
$99k
Disposed/sold 17,457 options to buy
@ $1.32, valued at
$23k
|
|
| 07/07/2016 |
4
| Jackson Scott Thomas (CEO) has filed a Form 4 on Celator Pharmaceuticals Inc|
Txns:
| Exercised 38,135 options to buy
@ $3.37, valued at
$128.5k
Exercised 117,064 options to buy
@ $2.44, valued at
$285.6k
Exercised 96,276 options to buy
@ $3.116, valued at
$300k
|
|
| 07/07/2016 |
4
| Powell Fred M (VP and CFO) has filed a Form 4 on Celator Pharmaceuticals Inc|
Txns:
| Exercised 71,887 options to buy
@ $3.116, valued at
$224k
|
|
| 07/01/2016 |
4
| Powell Fred M (VP and CFO) has filed a Form 4 on Celator Pharmaceuticals Inc|
Txns:
| Gifted 1,665 shares
@ $0 |
|
| 06/27/2016 |
4
| Powell Fred M (See Remarks) has filed a Form 4 on Celator Pharmaceuticals Inc|
Txns:
| Paid exercise price by delivering 2,491 shares
@ $30.15, valued at
$75.1k
Exercised 56,875 options to buy
@ $1.32, valued at
$75.1k
|
|
| 06/22/2016 |
4
| Kovner Bruce (See Remarks Section) has filed a Form 4 on Celator Pharmaceuticals Inc|
Txns:
| Gifted 88,571 shares
@ $0
Gifted 564,222 shares
@ $0
Gifted 564,222 shares
@ $0
Gifted 1,926 shares
@ $0 |
|
| 06/22/2016 |
4
| Valence Life Sciences GP II LLC (Member of a 10% Group) has filed a Form 4 on Celator Pharmaceuticals Inc |
| 03/17/2016 |
4
| Mayer Lawrence David (President and Head of Research) has filed a Form 4 on Celator Pharmaceuticals Inc |
| 11/08/2013 |
4
| Mayer Lawrence David (President and Head of Research) has filed a Form 4 on Celator Pharmaceuticals Inc |
| 08/07/2013 |
4
| VENTURES WEST CAPITAL LTD (10% Owner) has filed a Form 4 on Celator Pharmaceuticals Inc|
Txns:
| Acquired 156,831 shares
@ $0
Acquired 27,940 warrants
@ $5.2123, valued at
$145.6k
Acquired 77,811 warrants
@ $3.58, valued at
$278.6k
|
|
| 07/31/2013 |
4
| Kollender Richard S (Director) has filed a Form 4 on Celator Pharmaceuticals Inc |
| 07/31/2013 |
4
| QUAKER BIO VENTURES LP (10% Owner) has filed a Form 4 on Celator Pharmaceuticals Inc |
| 06/05/2013 |
4
| MOLLICA JOSEPH A (Director) has filed a Form 4 on Celator Pharmaceuticals Inc|
Txns:
| Granted 28,000 options to buy
@ $3.116, valued at
$87.2k
|
|
| 06/05/2013 |
4
| Mayer Lawrence David (Pres&Chief Scientific Officer) has filed a Form 4 on Celator Pharmaceuticals Inc |
| 06/05/2013 |
4
| Kollender Richard S (Director) has filed a Form 4 on Celator Pharmaceuticals Inc |
| 06/04/2013 |
4
| Zisson Alex (Director) has filed a Form 4 on Celator Pharmaceuticals Inc |
| 05/01/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|